189
Views
4
CrossRef citations to date
0
Altmetric
PHARMACEUTICAL ANALYSIS

Determination of Three Potential Genotoxic Impurities in Imatinib Mesylate by Gas Chromatography—Mass Spectrometry

, &
Pages 2337-2346 | Received 17 Sep 2015, Accepted 22 Jan 2016, Published online: 19 Jul 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Mohammed ALSaeedy, Arwa Al-Adhreai, Elif Mine Öncü-Kaya & Erol Şener. (2023) An Overview of Advances in the Chromatography of Drugs Impurity Profiling. Critical Reviews in Analytical Chemistry 53:7, pages 1455-1471.
Read now

Articles from other publishers (3)

Mayuri Kumari, Divya Bajpai Tripathy & Anjali Gupta. (2024) Analytical Methods and Their Significance in Pharmaceutical Process Impurities: A Review. Macromolecular Symposia 413:1.
Crossref
Liang-Liang Gao, Shulin Pang, Ying Gao, Donglei Shi & Yuan Guo. (2022) Recent development of organic small-molecule and nanomaterial fluorescent probes for hydrazine. Advanced Agrochem 1:1, pages 22-38.
Crossref
Fernanda Caroline Wolff, Thaís Luise Dillenburg, Marina Venzon Antunes, Rafael Linden, Sandrine Comparsi Wagner & Simone G. Verza. (2018) Characterization of imatinib mesylate formulations distributed in South American countries: Determination of genotoxic impurities by UHPLC–MS/MS and dissolution profile. Biomedical Chromatography 32:7.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.